EHA 2020: A new treatment paradigm in relapsed refractory Hodgkin lymphoma
Patients with relapsed/refractory classical Hodgkin lymphoma (R/R cHL) have few treatment options when they are…
Browsing: R/R cH
Trending
- Making Telehealth Human – Podcast
- Sign Up for The Oncology Newsletter | Our free weekly news roundup
- Improving immunotherapies for blood cancers: real-time exploration in the tumour
- Targeted delivery of highly toxic anti-cancer drug to brain tumours
- Study shows new treatment pathway to prevent and treat endometrial cancer recurrence
- Study uncovers inhibitory role of ‘Ter cells’ in cancer therapies
- Multiple myeloma: CAR T-cell therapy generates lasting remissions
- COVID-19 vaccination axillary adenopathy detected during breast imaging
- Antihypertensives can decrease bleomycin-induced lung injury
- How women make choices about surgery to prevent ovarian cancer
